Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Sarcoma 1Other neoplasm 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Leukemia, Myeloid, Acute 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Leukemia, Lymphocytic, Chronic, B-Cell 21Congenital Abnormalities 21Leukemia 20Lymphoma, Follicular 19Lymphoma, B-Cell, Marginal Zone 19Breast Neoplasms 19Multiple Myeloma 17Lymphoma, Mantle-Cell 17Myelodysplastic Syndromes 15Lymphoma, Non-Hodgkin 15Lymphoma, Large B-Cell, Diffuse 15Myeloproliferative Disorders 13Lymphoma, Large-Cell, Immunoblastic 13Lymphoma 13Burkitt Lymphoma 13Blast Crisis 13Lymphoma, T-Cell, Cutaneous 12Leukemia, Myelomonocytic, Chronic 12Leukemia, Myeloid, Accelerated Phase 12Sezary Syndrome 11Mycosis Fungoides 11Leukemia, Myeloid, Chronic-Phase 11Neoplasms, Plasma Cell 10Hodgkin Disease 10Waldenstrom Macroglobulinemia 9Primary Myelofibrosis 9Pdgfra-Associated Chronic Eosinophilic Leukemia 8Leukemia, Neutrophilic, Chronic 8

Interventions

Colposcopy 13Imiquimod 12Conization 11Papillomavirus Vaccines 8Cryotherapy 6Vaccines 5Papanicolaou Test 4Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4Acetic Acid 4Watchful Waiting 3Vaginal Smears 3Surveys and Questionnaires 3Biopsy 3human papillomavirus vaccine, L1 type 16, 18 2Spectrometry, Fluorescence 2Proflavine 2Mass Screening 2Immunohistochemistry 2Human Papillomavirus DNA Tests 2High-Throughput Screening Assays 2Flow Cytometry 2Curcumin 2Blood Specimen Collection 2pembrolizumab 1nimotuzumab 1lime 1human papillomavirus vaccine, TA 1hecolin 1efineptakin alfa 1Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Uterine Cervical Dysplasia × Flow Cytometry × Clear all
NCT00004261 2018-02-22

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

University Health Network, Toronto

Phase 1 Terminated
BreastGenitourinaryGynecologicHead & NeckSarcoma

Breast Carcinoma In Situ, Breast Neoplasms, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Inflammatory Breast Neoplasms

NCT00629577 2017-02-01

SAGE

British Columbia Cancer Agency

Phase 1 Terminated
50 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡